Although SLC7A11 deletion in tumor cells results in impaired tumor growth, neither systemic nor T-cell-specific knockout of SLC7A11 affects T cell proliferation or the antitumor immune response, suggesting that further investigation of the interplay between SLC7A11 and T cell function should be conducted (13, 151). Here, SLC7A11 is linked to neoplasm.